Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2020 07:00 ET | Source: Jounce Therapeutics, Inc.

Jounce Therapeutics Reports Third Quarter 2020 Financial Results

-On track to begin enrollment in the Phase 1 trial for JTX-8064 by year-end 2020- -Established exclusive license agreement with Gilead for JTX-1811- -Initiated the Phase 2 SELECT...
November 05, 2020 16:05 ET | Source: Alphatec Holdings, Inc.

ATEC Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights

U.S. Revenue Grows 43%Eighth Consecutive Quarter of Double-Digit Revenue Growth CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq:...
November 04, 2020 16:05 ET | Source: Playa Hotels & Resorts N.V.

Playa Hotels & Resorts N.V. Reports Third Quarter 2020 Results

FAIRFAX, Va., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Playa Hotels & Resorts N.V. (the “Company” or “Playa”) (NASDAQ: PLYA) today announced results of operations for the three and nine months ended...
October 30, 2020 08:00 ET | Source: Jounce Therapeutics, Inc.

Jounce Therapeutics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Friday, November 6, 2020

CAMBRIDGE, Mass., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
October 29, 2020 16:15 ET | Source: Piedmont Office Realty Trust, Inc.

Piedmont Office Realty Trust Reports Third Quarter 2020 Results

Atlanta, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust, Inc. ("Piedmont" or the "Company") (NYSE:PDM), an owner of Class A office properties located primarily in select sub-markets...
October 07, 2020 16:53 ET | Source: Alphatec Holdings, Inc.

ATEC Announces Preliminary Third Quarter 2020 Financial Results

Third quarter U.S. revenue expected to grow over 40%Eighth consecutive quarter of double-digit revenue growthRevenue per case expands on strong pull- through from SafeOp neuromonitoring and new...